Immunodiagnostics Market is Growing at a CAGR of 15.1% in 2026
is expected to rise from to an estimated value of USD 24.89 billion by 2026 registering a substantial CAGR of 7.80% in the forecast period of 2019-2026. This rise in the market can be attributed to rising prevalence of chronic diseases and technological advancements.
Key Market Competitors: Global Immunodiagnostics Market
Few of the major market competitors currently working in the immunodiagnostics market are Abbott., F. Hoffmann-La Roche Ltd, Danaher., Adaptive Biotechnologies., QIAGEN, AMARANTUS BIOSCIENCE HOLDINGS, INC., AESKU.GROUP GmbH & Co. KG, Avant Diagnostics, Inc., bioMérieux SA, Inova Diagnostics, Inc., OraSure Technologies, Myriad Genetics, Inc, Omega Diagnostics Group PLC, Nexus-Dx, Protagen, Quest Diagnostics Incorporated., Seramun Diagnostica GmbH., SQI Diagnostics, Tecan Trading AG, Siemens Healthcare GmbH, DiaSorin, Erba Diagnostics, Svar Life Science and Exagen Inc. amongst others.
Get Exclusive Sample Report: @
Immunodiagnostics is a diagnostic method that uses antigen-antibody reactions to measure the presence of molecules in biological fluids. It is used primarily for detecting and diagnosing infectious diseases, chronic diseases (cancer, cardiovascular diseases), autoimmune disease, hormonal disorder etc. These tests are also used to distinguish between compatible blood types. They provide precise, quick and accurate results and hence are gaining importance.
Competitive Analysis: Global Immunodiagnostics Market
Global immunodiagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of immunodiagnostics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Segmentation: Global Immunodiagnostics Market
· By Product (Reagents, Instruments, Software & Services)
· By Technology (ELISA, CLIA, RIA, FIA, Rapid Test, Others)
· By End User (Clinical Laboratories, Hospitals, Academic & Research Centers, Pharmaceutical & Biotechnology Industry, Diagno"
Author Signature :
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.